Englisch: Mercury toxicity presenting
as Chronic Fatigue, memory impairment and depression
Mercury toxicity presenting as Chronic Fatigue, memory impairment and
depression: Diagnosis, treatment, susceptibility, and outcomes in a
·
Wojcik DP,
·
Godfrey ME,
·
Christie D,
·
Haley BE.
Northland
Environmental Health Clinic,
In a group of 465 patients
diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue,
88.8% had memory loss, and 27.5% had depression. A significant correlation was
found between CMT and the Apo-lipoprotein E4 genotype
(p=0.001). An investigation into an additional 864 consecutively seen general
practice patients, resulted in 30.3% having evidence consistent with CMT, and
once again a significant correlation was found with the APO-E4 genotype
(p=0.001). Removal of amalgam mercury fillings when combined with appropriate
treatment resulted in a significant symptom reduction (p< 0.001) to levels
reported by healthy subjects.
Neuro Endocrinol Lett. 2006 Aug 5;27(4)
[Epub ahead of print] Links
PMID: 16891999 [PubMed - as supplied by publisher]
Related
Links
·
Apolipoprotein E genotyping as a potential biomarker for
mercury neurotoxicity. [J Alzheimers Dis.
2003] PMID: 12897404
·
DMSA
administration to patients with alleged mercury poisoning from dental amalgams:
a placebo-controlled study. [J Dent Res. 1994] PMID: 8163732
·
Health
status and quality of life in patients with early-stage Hodgkin's disease
treated on Southwest Oncology Group Study 9133. [J Clin Oncol. 2003] PMID: 12972528
·
Effect of
amalgam fillings on the mercury concentration in human amniotic fluid. [Arch
Gynecol Obstet. 2005] PMID: 14689312
·
Apolipoprotein E polymorphism in 385 patients on renal
replacement therapy in Sweden. [Scand J Urol
Nephrol. 2004] PMID: 1584178